Saudi Spimaco to complete pharmaceuticals plant by end of Q2-2016

22/02/2015 Argaam - Exclusive

Saudi Pharmaceutical Industries and Medical Appliances Corp. (Spimaco) expects to complete a pharmaceuticals plant owned by its subsidiary Dammam Pharma by the end of second quarter 2016, the company said in a reporton Sunday.

 

Dammam Pharma is 65 percent-owned by Spimaco and 20 percent-owned by Arak Healthcare, Spimaco’s wholly-owned marketing and distribution arm.

 

The pharmaceuticals manufacturer is expanding its plant in Saudi Arabias Al Qassim region to increase production capacity this year.

 

Spimaco also added that its restructuring Ibn Rushd, in which it has a 4.2 percent stake, to reverse losses.

 

Profit surged 19 percent last year to SAR 317 million, or SAR 2.64 a share, on higher sales, cutting costs and higher dividends from its investments in other companies.

 

Spimaco currently owns stakes in leading petrochemical companies across the kingdom, Yansab, Ibn Rushd, and Saudi Industrial Investment Group (SIIG).

 

The company produces several international pharmaceutical products under licenses, as well as generic drugs.

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.